Published in Gene Therapy Weekly, February 18th, 2010
"To identify additional cellular betaTrCP-dependent Vpu targets, we performed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.